Quantum Cyber N.V. current report, Q2 FY2023

Business Context and Reporting Period

This Form 6-K filing by Mainz Biomed N.V. (noted as Quantum Cyber N.V. in metadata) covers the month of June 2023, with a specific reporting date of June 28, 2023. The registrant is a foreign private issuer headquartered in Mainz, Germany. The filing primarily reports on the results of the Annual General Meeting and the entry into a material definitive financing agreement.

Key Financial Metrics and Capital Structure

The filing details a new financing facility rather than standard operating financial results (revenue, profit, or cash flow) for the period.

  • Financing Facility: Entered into a Pre-Paid Advance Agreement (PPA) with YA II PN, Ltd. ("Yorkville") for a commitment amount of up to $50,000,000 in promissory notes.
  • Initial Transaction: Sold an Initial Promissory Note with a principal amount of $5,500,000.
  • Discount Rate: Notes are purchased at 92% of the principal amount.
  • Commitment Fee: Paid $250,000 in the form of 54,428 ordinary shares.
  • Interest Terms: Notes carry no interest unless an event of default occurs, at which point interest increases to 15% per annum.
  • Prepayment Penalty: Prepayment requires an 8% premium.

Material Changes and Agreement Terms

The primary material change is the execution of the PPA, which introduces specific obligations and conversion mechanics:

  • Conversion Price: Yorkville may convert notes into ordinary shares at a price equal to the lower of a fixed price (initially $4.9986) or 92% of the average of the two lowest daily VWAPs in the eight trading days prior to conversion. A floor price of $2.00 applies.
  • Trigger Event: If the share price trades below the Floor Price for five of seven consecutive trading days, the company must make monthly cash payments to Yorkville. These payments are capped at the lesser of $550,000 plus premiums or the total outstanding principal plus premiums.
  • Advance Notices: The company may sell shares to Yorkville up to the commitment amount. Sales are limited to the greater of 100% of the 5-day average daily volume or 550,000 shares per notice, priced at 92% of the market price.
  • Ownership Cap: Yorkville cannot beneficially own more than 4.99% of the company's ordinary shares.
  • Restriction on Other Facilities: The company cannot utilize its existing $50 million Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. while Promissory Notes are outstanding, unless specific price conditions are met.
  • Outlook, Risks, and Management Commentary

    The filing highlights significant liquidity and dilution risks associated with the new agreement:

    • Liquidity Risk: The company may be unable to raise additional capital through its Cantor Agreement while the Yorkville notes are outstanding, limiting access to alternative funding sources.
    • Cash Flow Obligation: The "Trigger Event" mechanism creates a potential recurring monthly cash outflow obligation if the stock price remains depressed, which could strain liquidity.
    • Dilution Risk: The agreement allows for significant share issuance through conversion, Advance Notices, and Investor Notices, subject to the 4.99% ownership cap.
    • Management Commentary: The filing states that the company held its Annual General Meeting on June 28, 2023, with results attached as an exhibit, but provides no specific commentary on operational performance or future guidance within the text of this report.
    • Investor Verification Checklist

      • Verify the exact number of shares issued for the $250,000 commitment fee and the impact on current share count.
      • Review the full text of the Pre-Paid Advance Agreement (Exhibit 10.1) to understand the specific conditions for the "Trigger Event" and monthly payment calculations.
      • Confirm the current trading price relative to the $2.00 Floor Price and the $4.9986 Fixed Price to assess immediate conversion or payment risks.
      • Check the status of the Annual General Meeting results (Exhibit 99.1) for any shareholder approvals related to this financing.
      • Monitor the company's ability to access the Cantor Fitzgerald facility given the new restrictions imposed by the Yorkville agreement.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.